Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Daily News

Guiding DAPT Based on Genes or Platelet Tests Still ‘Tempting’

Yael L. Maxwell

November 08, 2023

Presentation TCT 2023

TCT 11: Clinical impact of dyspnea after ticagrelor treatment and the effect of switching to clopidogrel in patients with myocardial infarction

Presenter: Sang Hyun Kim

October 25, 2023

Presentation TCT 2023

TCT 507: Association of CYP2C19*17 Carrier Status to Ischemic and Bleeding Outcomes Among Patients with Coronary Artery Disease Treated with Clopidogrel: a Meta-Analysis

Presenter: Cole Clifford

October 25, 2023

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

Presentation TCT 2023

Aspirin or Clopidogrel for Chronic Management?

Presenter: Fausto Feres

October 24, 2023

Presentation TCT 2023

Clopidogrel Monotherapy Following 1-month DAPT versus Aspirin Monotherapy Following 12-month DAPT in Patients Receiving PCI; Final 5-year Result of STOPDAPT-2

Presenter: Hirotoshi Watanabe

October 23, 2023

News Daily News

Clopidogrel Bests Aspirin Monotherapy After PCI Across Risk Strata

Yael L. Maxwell

October 09, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

Todd Neale

September 13, 2023

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

News Daily News

Unguided De-escalation, Short DAPT the Best Strategies in ACS: Meta-analysis

Yael L. Maxwell

September 05, 2023

News Conference News ESC 2023

Avoid Using Prasugrel With Cangrelor During PCI, SWAP-6 Affirms

Todd Neale

August 22, 2023

News Opinion Editor's Corner ESC 2023

What’s Going to Be Hot at ESC 2023?

Shelley Wood

August 15, 2023

News Daily News

Prehospital Cath Lab Activation in Australia Linked to Better STEMI Survival

L.A. McKeown

July 20, 2023

News Conference News SCAI 2023

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

L.A. McKeown

May 22, 2023

News Daily News

A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4

Shelley Wood

April 14, 2023

News Conference News ACC 2023

STREAM-2: Half-Dose Tenecteplase Safe, Effective in Older STEMI Patients

L.A. McKeown

March 10, 2023

News Conference News ACC 2023

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

Yael L. Maxwell

March 09, 2023

News Conference News CRT 2023

In CABG/PCI Decisions for Left Main Disease, Diabetes ‘Still Matters’

Yael L. Maxwell

March 01, 2023

News Daily News

P2Y12 Monotherapy Better Than Continued DAPT Even After Complex PCI

Yael L. Maxwell

February 06, 2023

Advertisement

Guiding DAPT Based on Genes or Platelet Tests Still ‘Tempting’

TCT 11: Clinical impact of dyspnea after ticagrelor treatment and the effect of switching to clopidogrel in patients with myocardial infarction

TCT 507: Association of CYP2C19*17 Carrier Status to Ischemic and Bleeding Outcomes Among Patients with Coronary Artery Disease Treated with Clopidogrel: a Meta-Analysis

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Aspirin or Clopidogrel for Chronic Management?

Clopidogrel Monotherapy Following 1-month DAPT versus Aspirin Monotherapy Following 12-month DAPT in Patients Receiving PCI; Final 5-year Result of STOPDAPT-2

Clopidogrel Bests Aspirin Monotherapy After PCI Across Risk Strata

October 2023 News Roundup

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Unguided De-escalation, Short DAPT the Best Strategies in ACS: Meta-analysis

Avoid Using Prasugrel With Cangrelor During PCI, SWAP-6 Affirms

What’s Going to Be Hot at ESC 2023?

Prehospital Cath Lab Activation in Australia Linked to Better STEMI Survival

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4

STREAM-2: Half-Dose Tenecteplase Safe, Effective in Older STEMI Patients

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

In CABG/PCI Decisions for Left Main Disease, Diabetes ‘Still Matters’

P2Y12 Monotherapy Better Than Continued DAPT Even After Complex PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content